Association of Selected STAT Inhibitors with Prolactin-Induced Protein (PIP) in Breast Cancer
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041416 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Karolina Jabłońska und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Histology and Embryology, Department of Human Morphology and Embryology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw,…. Hauptthemen laut MEDLINE: Breast Neoplasms, STAT5 Transcription Factor, Protein Inhibitors of Activated STAT, Molecular Chaperones. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Science and Higher Education in the "Regional Initiative of Excellence programme for the years 2019-2022", The Ministry of Science and Higher Education.
Abstract (Originalsprache)
Breast cancer (BC) is the most common cancer in women, and a higher level of prolactin-induced protein (PIP) is associated with better responses to adjuvant chemotherapy. The signal transducer and activator of transcription 5 (STAT5) is a potential regulator of the PIP gene. Prolactin (PRL) and its receptor (PRLR) activate JAK2/STAT5 signaling in BC, which is modulated by inhibitors like suppressors of cytokine signaling (SOCS) proteins and protein inhibitors of activated STAT (PIAS). Using real-time PCR and immunohistochemistry, we studied the relationship between PIP and STAT5 inhibitors in BC. Our findings indicated that PIP and STAT5 levels decrease with a higher tumor grade, size, and tumor/nodes/metastasis (TNM) clinical stage, while nuclear PIAS3 levels increase with tumor progression. Both STAT inhibitors are linked to estrogen and progesterone receptor status. Notably, STAT5 correlates positively with PIP, SOCS3, and PIAS3, suggesting that it may be a favorable prognostic factor. Among the STAT inhibitors, only nuclear PIAS3 expression correlates with PIP. In vitro studies indicated that silencing PIAS3 in T47D cells does not affect PIP expression or sensitivity to doxorubicin (DOX), but T47D control cells with a higher PIP expression are more sensitive to DOX, highlighting the need for further investigation into these mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Histology and Embryology, Department of Human Morphology and Embryology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland.
- Department of Biochemistry and Molecular Biology, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.
- Department of Pathology, Polish Mother Memorial Hospital-Research Institute, 93-338 Lodz, Poland.
- Department of Oncology, Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland.
- Lower Silesian Oncology, Pulmonology and Hematology Center, 53-413 Wroclaw, Poland.
- Department of Human Biology, Faculty of Physiotherapy, Wroclaw University of Health and Sport Sciences, 51-612 Wroclaw, Poland.
ORCID-Profile: Karolina Jabłońska, Katarzyna Nowińska, Aleksandra Piotrowska, Jarosław Suchański, Katarzyna Ratajczak-Wielgomas, Aleksandra Partyńska, Beata Smolarz, Rafał Matkowski
Förderung
- The Ministry of Science and Higher Education in the "Regional Initiative of Excellence programme for the years 2019-2022"
- The Ministry of Science and Higher Education
Zitieren
APA
Jabłońska, K., Kmiecik, A., Nowińska, K., Piotrowska, A., Suchański, J., Ratajczak-Wielgomas, K., Partyńska, A., Romanowicz, H., Smolarz, B., Matkowski, R., & Dzięgiel, P. (2025). Association of Selected STAT Inhibitors with Prolactin-Induced Protein (PIP) in Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041416
Vancouver
Jabłońska K, Kmiecik A, Nowińska K, Piotrowska A, Suchański J, Ratajczak-Wielgomas K, et al. Association of Selected STAT Inhibitors with Prolactin-Induced Protein (PIP) in Breast Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041416
BibTeX
@article{Jaboska2025,
author = {Jabłońska, Karolina and Kmiecik, Alicja and Nowińska, Katarzyna and Piotrowska, Aleksandra and Suchański, Jarosław and Ratajczak-Wielgomas, Katarzyna and Partyńska, Aleksandra and Romanowicz, Hanna and Smolarz, Beata and Matkowski, Rafał and Dzięgiel, Piotr},
title = {Association of Selected STAT Inhibitors with Prolactin-Induced Protein (PIP) in Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041416}
}
EUVIMED